{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:45:30Z","timestamp":1785527130788,"version":"3.56.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020043","name":"Yeditepe University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020043","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To assess the dose-response and dose-survival outcomes of yttrium-90 (Y90) transarterial radioembolization (TARE) using Therasphere microspheres in patients with colorectal cancer liver metastases (CRCLM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>Between May 2014 and December 2024, patients with chemorefractory CRCLM who underwent Y90 TARE using glass microspheres were retrospectively included. Patients were divided into two groups according to tumour absorbed dose (TAD): TAD&lt;189 Gy (group 1) and TAD \u2265189 Gy (group 2). The primary outcomes were overall survival (OS) and hepatic progression-free survival (hPFS). The secondary outcome was the objective response rate (ORR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of seventy-eight patients with a mean age of 69.9\u00b111.2 years (range 41 to 91 years) were included. The median tumor dose and the median OS were 171.5 Gy (IQR; 147-200 Gy) and 8.9 months ( IQR; 5-14 months), respectively. The median TAD for groups 1 (n=46) and 2 (n=32) was 150 Gy (IQR; 122-166 Gy) and 202 Gy (IQR; 195-232 Gy), respectively. The median OS and hPFS for group 1 versus group 2 were 9.4 months (IQR; 6.7\u201317.7 months) and 5.2 months (IQR; 4-6.7 months) versus 7.1 months (IQR; 5\u201310.7 months) and 5.5 months (IQR; 4.2-6.7 months), respectively and were not significantly different (p = .107 and p = .663, respectively). The ORR did not differ significantly between the two groups (p = .943).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In a real-world population of heavily pretreated patients with CRCLM, escalation of TAD beyond 189 Gy did not translate into improved survival, highlighting the dominant impact of advanced disease burden and extrahepatic progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00259-026-07933-z","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:46:08Z","timestamp":1779410768000},"page":"5868-5878","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor absorbed dose and outcomes after Y-90 glass radioembolization for colorectal liver metastases: does dose escalation improve survival in real-world practice?"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4008-3395","authenticated-orcid":false,"given":"Osman Melih","family":"Topcuoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9228-3703","authenticated-orcid":false,"given":"Betul","family":"Uzunoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3569-0297","authenticated-orcid":false,"given":"Tolga","family":"Orhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3161-0051","authenticated-orcid":false,"given":"Ismail Necim","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5620-2881","authenticated-orcid":false,"given":"Ay\u015fegul","family":"Gormez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turkay","family":"Toklu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0912-8214","authenticated-orcid":false,"given":"Nalan Alan","family":"Selcuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"7933_CR1","first-page":"89","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14:89\u2013103.","journal-title":"Prz Gastroenterol"},{"key":"7933_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.5005\/jp-journals-10018-1241","volume":"7","author":"AI Valderrama-Trevi\u00f1o","year":"2017","unstructured":"Valderrama-Trevi\u00f1o AI, Barrera-Mera B, Ceballos-Villalva JC, MontalvoJav\u00e9 EE. Hepatic metastasis from colorectal cancer. Euroasian J Hepatogastroenterol. 2017;7:166\u201375.","journal-title":"Euroasian J Hepatogastroenterol"},{"issue":"Suppl 2","key":"7933_CR3","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.2967\/jnumed.116.187229","volume":"58","author":"FE Boas","year":"2017","unstructured":"Boas FE, Bodei L, Sofocleous CT. Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes. J Nucl Med. 2017;58(Suppl 2):S104\u201311.","journal-title":"J Nucl Med"},{"key":"7933_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s12094-023-03299-y","volume":"26","author":"E Gonz\u00e1lez-Flores","year":"2024","unstructured":"Gonz\u00e1lez-Flores E, Zambudio N, Pardo-Moreno P, Gonzalez-Astorga B, de la R\u00faa JR, Trivi\u00f1o-Ib\u00e1\u00f1ez EM, Navarro P, Espinoza-C\u00e1mac N, Casado M\u00c1. Rodr\u00edguez-Fern\u00e1ndez A. Recommendations for the management of yttrium-90 radioembolization in the treatment of patients with colorectal cancer liver metastases: a multidisciplinary review. Clin Transl Oncol. 2024;26:851\u201363.","journal-title":"Clin Transl Oncol"},{"key":"7933_CR5","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.2967\/jnumed.120.255745","volume":"62","author":"AA Alsultan","year":"2021","unstructured":"Alsultan AA, van Roekel C, Barentsz MW, Smits MLJ, Kunnen B, Koopman M, Braat AJAT, Bruijnen RCG, de Keizer B, Lam MGEH. Dose-Response and Dose-Toxicity Relationships for Glass 90Y Radioembolization in Patients with Liver Metastases from Colorectal Cancer. J Nucl Med. 2021;62:1616\u201323.","journal-title":"J Nucl Med"},{"key":"7933_CR6","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s00259-021-05600-z","volume":"49","author":"M Weber","year":"2022","unstructured":"Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P, Gnesin S, Bodei L, Kracmerova T, Luster M, Garin E, Herrmann K. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging. 2022;49:1682\u201399.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7933_CR7","first-page":"1097","volume":"66","author":"C Soydal","year":"2025","unstructured":"Soydal C, Araz M, Demir B, Ones T, Sonmezoglu K, Selcuk NA, Balli T, Is\u0131k EG, Salanc\u0131 BV, Derebek E, Kesim S, Sahin OE, Piskin FC, Celebioglu EC, Bilgic MS, Kucuk NO. Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival. J Nucl Med. 2025;66:1097\u2013104.","journal-title":"J Nucl Med"},{"key":"7933_CR8","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1007\/s00259-022-05774-0","volume":"49","author":"M Lam","year":"2022","unstructured":"Lam M, Garin E, Maccauro M, Kappadath SC, Sze DY, Turkmen C, Cantasdemir M, Haste P, Herrmann K, Alsuhaibani HS, Dreher M, Fowers KD, Salem R. A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study. Eur J Nucl Med Mol Imaging. 2022;49:3340\u201352.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7933_CR9","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1200\/JCO.21.01839","volume":"39","author":"MF Mulcahy","year":"2021","unstructured":"Mulcahy MF, Mahvash A, Pracht M, Montazeri AH, Bandula S, Martin RCG 2nd, Herrmann K, Brown E, Zuckerman D, Wilson G, Kim TY, Weaver A, Ross P, Harris WP, Graham J, Mills J, Yubero Esteban A, Johnson MS, Sofocleous CT, Padia SA, Lewandowski RJ, Garin E, Sinclair P, Salem R. EPOCH Investigators. Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial. J Clin Oncol. 2021;39:3897\u2013907.","journal-title":"J Clin Oncol"},{"key":"7933_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1148\/radiol.220387","volume":"305","author":"EC Emmons","year":"2022","unstructured":"Emmons EC, Bishay S, Du L, Krebs H, Gandhi RT, Collins ZS, O\u2019Hara R, Akhter NM, Wang EA, Grilli C, Brower JS, Peck SR, Petroziello M, Abdel Aal AK, Golzarian J, Kennedy AS, Matsuoka L, Sze DY, Brown DB. Survival and Toxicities after 90Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry. Radiology. 2022;305:228\u201336.","journal-title":"Radiology"},{"key":"7933_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1148\/radiol.221345","volume":"305","author":"RP Liddell","year":"2022","unstructured":"Liddell RP. 90Y Transarterial Radioembolization for Metastatic Colorectal Cancer. Radiology. 2022;305:237\u20138.","journal-title":"Radiology"},{"key":"7933_CR12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.2967\/jnumed.115.166942","volume":"57","author":"AF van den Hoven","year":"2016","unstructured":"van den Hoven AF, Rosenbaum CE, Elias SG, de Jong HW, Koopman M, Verkooijen HM, Alavi A, van den Bosch MA, Lam MG. Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases. J Nucl Med. 2016;57:1014\u20139.","journal-title":"J Nucl Med"},{"key":"7933_CR13","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.jvir.2023.08.031","volume":"34","author":"PW Doyle","year":"2023","unstructured":"Doyle PW, Workman CS, Shah N, McGonigle TW, Grice JV, Huang S, Borgmann AJ, Baker JC, Guys NP, Taylor JE, Brown DB. Predictive Partition Dosimetry and Outcomes after Yttrium-90 Resin Microsphere Radioembolization of Colorectal Cancer Metastatic to the Liver: A Retrospective Analysis. J Vasc Interv Radiol. 2023;34:2138\u201346.","journal-title":"J Vasc Interv Radiol"},{"key":"7933_CR14","doi-asserted-by":"crossref","unstructured":"Dimopoulos MP, Sotirchos VS, Dunne-Jaffe C, Mitchell A, Petre EN, Alexander ES, Gonen M, Rao D, Connell LC, Soares K, Katsanos K, Sofocleous CT. Tumor Absorbed Dose Predicts Survival and Local Tumor Control in Colorectal Liver Metastases Treated with 90Y Radioembolization. Cardiovasc Intervent Radiol. 2025 Sep 9.","DOI":"10.1007\/s00270-025-04175-8"},{"key":"7933_CR15","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s00270-020-02463-z","volume":"43","author":"A Dabrowiecki","year":"2020","unstructured":"Dabrowiecki A, Sankhla T, Shinn K, Bercu ZL, Ermentrout M, Shaib W, Cardona K, Newsome J, Kokabi N. Impact of Genomic Mutation and Timing of Y90 Radioembolization in Colorectal Liver Metastases. Cardiovasc Intervent Radiol. 2020;43:1006\u201314.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"7933_CR16","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.3390\/cancers16132401","volume":"16","author":"J Yeakel","year":"2024","unstructured":"Yeakel J, Seyedin SN, Harada G, Hagopian G, Mahmood S, Bennett R, Harris JP, Abbott EM, Lindner S, Dayyani F, Sehgal V, Kuo JV, Abi-Jaoudeh N. The Impact of Local Control on Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Cancer: A Retrospective Analysis. Cancers (Basel). 2024;16:2401.","journal-title":"Cancers (Basel)"},{"key":"7933_CR17","first-page":"8","volume":"18","author":"I Kurilova","year":"2019","unstructured":"Kurilova I, Beets-Tan RGH, Flynn J, G\u00f6nen M, Ulaner G, Petre EN, Edward Boas F, Ziv E, Yarmohammadi H, Klompenhouwer EG, Cercek A, Kemeny NA, Sofocleous CT. Factors Affecting Oncologic Outcomes of 90Y Radioembolization of Heavily Pre-Treated Patients With Colon Cancer Liver Metastases. Clin Colorectal Cancer. 2019;18:8\u201318.","journal-title":"Clin Colorectal Cancer"},{"key":"7933_CR18","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s00270-023-03391-4","volume":"46","author":"G Maleux","year":"2023","unstructured":"Maleux G, Albrecht T, Arnold D, Bargellini I, Cianni R, Helmberger T, Kolligs F, Munneke G, Peynircioglu B, Sangro B, Schaefer N, Pereira H, Zeka B, de Jong N, Bilbao JI. CIRT Principal Investigators. Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study. Cardiovasc Intervent Radiol. 2023;46:852\u201367.","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07933-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07933-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07933-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:09:05Z","timestamp":1785521345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07933-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["7933"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07933-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required. Local Institutional Review Board (IRB) approved this study.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this type of study informed consent is not required.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}